Among men and women in a generalized epidemic, the initiation of antiretroviral therapy (ART) at a CD4 cell count between 350–550 cells/μl was shown to prevent 96% of new infections as compared to treatment initiation at CD4 <250 cells/μl [4, 5]. This evidence concerns the gene CD4 and infection.